Stocks are fluid, trying to go with the flow to make some $$$.
By the time news=hot stock, the party's already over.
If a stock pops big for no reason=it's a trap. Pump and Dump.
99% of the time, rumors are unmerited and buyouts will not occur.
Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease.
20 y/o. Stocks & Options. Venture Capital & Startups. @BusinessInsider 20 Under 20. Momentum & Biotech Emphasis. Founder of BioStocks LLC. Not always on stock twits (Real twitter is linked). Brett@BioStocks.com Feel free to connect!
Analyst with experience as prop trader on the Street as well as working in asset management. CFA candidate and Seeking Alpha writer. Specializing in value biotech and write Biotech Weekly. Personal opinions, not investment advice.